Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
The likelihood of a 50 basis point Fed rate cut increases, with a possible start in September

The likelihood of a 50 basis point Fed rate cut increases, with a possible start in September

ChaincatcherChaincatcher2025/08/13 12:19
Show original

According to ChainCatcher, citing Jinshi News, U.S. Treasury Secretary Bessent stated in an interview that the Federal Reserve’s interest rates should be 150-175 basis points lower than current levels, and believes there is a strong possibility of a 50 basis point rate cut, potentially starting in September. He also mentioned that the Fed does not need to reintroduce large-scale asset purchases (QE), and emphasized the need for reliable employment data. Analysts pointed out that the likelihood of the Fed cutting rates by 50 basis points in September is nearly zero and will depend on the performance of the nonfarm payroll report.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Starbucks (SBUX.US) officially refutes rumors: clearly denies acquiring Chipotle (CMG.US), focuses on "Back to Starbucks" transformation strategy

Starbucks publicly clarified on Monday that the company has not acquired Chipotle Mexican Grill, putting an end to the previous acquisition rumors.

智通财经•2026/10/12 23:31

BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized

BlackRock has turned bullish on U.S. Treasury bonds for the first time in six years, upgrading short-term bonds to overweight and downgrading U.S. equities to neutral, stating that rate hike expectations are excessive and it is time to lock in yields.

智通财经•2026/10/12 23:27
BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized

AstraZeneca (AZN.US) Relizumab's new indication is expected to be included in priority review

Relizumab is a blockbuster product under AstraZeneca, with global sales projected to reach 4.718 billions USD in 2025 (YOY +20.23%).

智通财经•2026/10/12 23:11